BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11079671)

  • 1. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy.
    Kakishita M; Kurita T; Matsuo K; Taguchi A; Suyama K; Shimizu W; Aihara N; Kamakura S; Yamamoto F; Kobayashi J; Kosakai Y; Ohe T
    J Am Coll Cardiol; 2000 Nov; 36(5):1646-53. PubMed ID: 11079671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature ventricular complexes as a trigger for ventricular fibrillation.
    Sánchez Muñoz JJ; García-Alberola A; Martínez-Sánchez J; Peñafiel-Verdú P; Caro-Martínez C; Manzano-Fernández S; Valdés Chávarri M
    Rev Esp Cardiol; 2010 Jul; 63(7):798-801. PubMed ID: 20609313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome.
    Kanda M; Shimizu W; Matsuo K; Nagaya N; Taguchi A; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(11):1799-805. PubMed ID: 12039494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation.
    Li L; Ding L; Zhou L; Wu L; Zheng L; Zhang Z; Xiong Y; Zhang Z; Yao Y
    Europace; 2023 Dec; 26(1):. PubMed ID: 37889958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E; Cappelli S; Cappato R
    Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract]   [Full Text] [Related]  

  • 6. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.
    Stix G; Bella PD; Carbucicchio C; Schmidinger H
    J Cardiovasc Electrophysiol; 2000 May; 11(5):516-21. PubMed ID: 10826930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome.
    Nam GB; Ko KH; Kim J; Park KM; Rhee KS; Choi KJ; Kim YH; Antzelevitch C
    Eur Heart J; 2010 Feb; 31(3):330-9. PubMed ID: 19880418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome.
    Matsuo K; Kurita T; Inagaki M; Kakishita M; Aihara N; Shimizu W; Taguchi A; Suyama K; Kamakura S; Shimomura K
    Eur Heart J; 1999 Mar; 20(6):465-70. PubMed ID: 10213350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome].
    Binbin Y; Jingping L; Bing Y; Minglong C; Jiangang Z; Kejiang C; Qijun S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):690-4. PubMed ID: 26955725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome.
    Nakagawa E; Takagi M; Tatsumi H; Yoshiyama M
    Circ J; 2008 Jun; 72(6):1025-9. PubMed ID: 18503235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome.
    Belhassen B; Viskin S; Fish R; Glick A; Setbon I; Eldar M
    J Cardiovasc Electrophysiol; 1999 Oct; 10(10):1301-12. PubMed ID: 10515552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brugada syndrome].
    Matsuo K; Yano K
    Nihon Rinsho; 2002 Jul; 60(7):1408-14. PubMed ID: 12136622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms.
    Swerdlow CD; Zhou X; Voroshilovsky O; Abeyratne A; Gillberg J
    Heart Rhythm; 2008 May; 5(5):670-6. PubMed ID: 18452868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators.
    Anthony R; Daubert JP; Zareba W; Andrews ML; McNitt S; Levine E; Huang DT; Hall WJ; Moss AJ;
    Pacing Clin Electrophysiol; 2008 Feb; 31(2):144-50. PubMed ID: 18233965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome.
    Takigawa M; Noda T; Shimizu W; Miyamoto K; Okamura H; Satomi K; Suyama K; Aihara N; Kamakura S; Kurita T
    Heart Rhythm; 2008 Nov; 5(11):1523-7. PubMed ID: 18984526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.